Position in ELAN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$387,804
+$69,440 QoQ
Shares Held
15,758
+18.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#306
of 515 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Oakmont Advisory Group, LLC holds $1,297,099 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (29.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,639 | $444,777 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
15,758 | $387,804 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
700 | $379,281 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
376 | $41,713 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
1,111 | $38,518 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
527 | $2,598 | |
| 7 | HLN |
Haleon plc
|
205 | $1,912 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
31 | $496 |
All Filings in ELAN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $387,804 | 15,758 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $318,364 | 13,304 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $316,231 | 13,974 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||